Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.

Khalsa, Jag; Duffy, Linda C; Riscuta, Gabriela; Starke-Reed, Pamela; Hubbard, Van S

Khalsa, Jag; Duffy, Linda C; Riscuta, Gabriela; Starke-Reed, Pamela; Hubbard, Van S.

Afiliación

Khalsa J; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
Duffy LC; National Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, MD, USA.
Riscuta G; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Starke-Reed P; Agricultural Research Service, United States Department of Agriculture, Washington, DC, USA.
Hubbard VS; Formerly National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

Clin Pharmacol Drug Dev ; 6(2): 176-185, 2017 Mar.

Article en En | MEDLINE | ID: mdl-28263462

Asunto(s)

Mucosa Intestinal/metabolismo; Hígado/metabolismo; Microbiota; Animales; Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos; Humanos; Preparaciones Farmacéuticas/metabolismo; Medicina de Precisión

Palabras clave

gut-liver-metabolic network; microbiome; omics; precision medicine; probiotics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Microbiota / Mucosa Intestinal / Hígado Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google